NU

Nucleome

2 known investors

nucleome.com ↗

Nucleome develops 3D genomics technology to map genetic variants in the non-coding genome to the genes they dysregulate, with applications in understanding inflammatory diseases and discovering therapeutic targets. The company builds a data atlas of immune system dysregulation to enable development of genetically-informed therapeutics for inflammatory conditions.

Investors · 2

M

M VenturesLos Angeles · $10.8M

PF

Pfizer Venture Investments$5M – $20M